Consensus Concord Biotech Limited

Equities

CONCORDBIO

INE338H01029

Delayed NSE India S.E. Other stock markets 09:57:28 23/05/2024 BST			5-day change	1st Jan Change
1,453 ^INR	-0.47%		-0.33%	-1.25%

03-18	Concord Biotech Limited(BSE:543960) added to S&P Global BMI Index	CI
03-06	Concord Biotech's API Plant Gets GMP Certificate from Brazilian Health Regulator	MT

Evolution of the average Target Price on Concord Biotech Limited

Price target over the last 5 years

History of analyst recommendation changes

ac18188c8278420863d3.0zS_MpFQYkESRTxhC0Eqp69IbtLqDiZPKzxNwJTxJY8.4WfGA-YgDC12L0oVMwtdlZ0aN-O5QW8CTlMql92bet7kRv1T8jNVMlkaTw~71b7d7816d209417eab0b6808ffe1c9b

Analyst Recommendations on Concord Biotech Limited

Jefferies Adjusts Concord Biotech’s Price Target to INR1,410 From INR1,440, Keeps at Hold	02-12	MT
Jefferies Downgrades Concord Biotech to Hold From Buy, Adjusts Price Target to INR1,300 From INR1,260	11-10	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

1,460 INR

Average target price

1,597 INR

Spread / Average Target

+9.36%

High Price Target

1,720 INR

Spread / Highest target

+17.80%

Low Price Target

1,410 INR

Spread / Lowest Target

-3.43%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Concord Biotech Limited

Jefferies & Co.

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar